The approach to community-acquired pneumonia: A survey study

Ertürk, Arzu; AYDEMİR, Yusuf; ÖZHAN, Mustafa Hikmet; AKINCI ÖZYÜREK, Berna; ALİZOROĞLU, Dursun; Sen, Nazan

doi:10.4103/ejop.ejop_37_18

The approach to community-acquired pneumonia: A survey study

Berna AKINCI ÖZYÜREK, (Atatürk Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitim ve Araştırma Hastanesi, Göğüs Hastalıkları Kliniği, Ankara, Türkiye)

Arzu ERTÜRK, (Ahi Evran Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Kırşehir, Türkiye)

Yusuf Aydemir, (Sakarya Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Sakarya, Türkiye)

NAZAN ŞEN, (Başkent Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Adana, Türkiye)

Dursun ALİZOROĞLU, (Suat Seren Göğüs Hastalıkları ve Göğüs Cerrahisi Eğitimi ve Araştırma Hastanesi, Göğüs Hastalıkları Kliniği, İzmir, Türkiye)

Mustafa Hikmet ÖZHAN (Ege Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, İzmir, Türkiye)

Eurasian Journal of Pulmonology

0 0

Yıl: 2018 Cilt: 20 Sayı: 2 Sayfa Aralığı: 93 - 98 Metin Dili: İngilizce DOI: 10.4103/ejop.ejop_37_18 İndeks Tarihi: 17-07-2020

The approach to community-acquired pneumonia: A survey study

Öz:

INTRODUCTION AND AIM: Community-acquired pneumonia (CAP), which is often seen in dailypractice, is a lower respiratory tract and pulmonary parenchyma infection which develops in societyand daily life with community-acquired pathogens in individuals with no known immune failure. Delayin the treatment of pneumonia is known to increase morbidity and mortality. Various scoring systemsare currently used in the identification of treatment groups in pneumonia. With the aim of evaluatingthe approach to CAP cases, the infection.MATERIALS AND METHODS: Working Group of the Turkish Respiratory ResearchAssociation (TUSAD) prepared a 22-item questionnaire.RESULTS: The survey was published on the TUSAD official website between July 2013 and June2016. A total of 78 individuals responded to the questionnaire on the website.CONCLUSION: The responses to the questionnaire could indicate the way forward for newguidelines for physicians in respect of the approach to CAP.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Bulbul Y. Community-Acquired Pneumonia Data in Turkey, Current Chest Disease Series 2014;2:1-10.
2. Guest JF, Morris A. Community‑acquired pneumonia: The annual cost to the national health service in the UK. Eur Respir J 1997;10:1530‑4.
3. Türkiye İstatistik Kurumu. Sağlık İstatistikleri; 2004. Available from: http://www.tuik.gov.tr. [Last accessed on 2017 Dec 16].
4. Sintes H, Sibila O, Waterer GW, Chalmers JD. Severity assesment tools in CAP. Eur Respir Monogr 2014;63:88‑104.
5. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for medicare patients hospitalized with community‑acquired pneumonia. Arch Intern Med 2004;164:637‑44.
6. Musher DM, Roig IL, Cazares G, Stager CE, Logan N, Safar H, et al. Can an etiologic agent be identified in adults who are hospitalized for community‑acquired pneumonia: Results of a one‑year study. J Infect 2013;67:11‑8.
7. Gwatkin DR. Acute respiratory infections in under‑fives: 15 million deaths a year. Lancet 1985;2:699‑701.
8. Pio A, Leowski J Luelmo F. Epidemiological magnitude of the problem of acute respiratory infections in children in developing countries. Bull IUAT 1983;58:199.
9. Centers for Disease Control and Prevention. Introduction to table V. Premature deaths, monthly mortality, and monthly physician contacts – United States. MMWR Morb Mortal Wkly Rep 1997;46:556‑61.
10. Pinner RW, Teutsch SM, Simonsen L, Klug LA, Graber JM, Clarke MJ, et al. Trends in infectious diseases mortality in the United States. JAMA 1996;275:189‑93.
11. Marston BJ, Plouffe JF, File TM Jr., Hackman BA, Salstrom SJ, Lipman HB, et al. Incidence of community‑acquired pneumonia requiring hospitalization. Results of a population‑based active surveillance study in Ohio. The Community‑Based Pneumonia İncidence Study Group. Arch Intern Med 1997;157:1709‑18.
12. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community‑acquired pneumonia. Clin Ther 1998;20:820‑37.
13. T. C. Ministry of Health. Refik Saydam Hygiene Center Presidency Hıfzıssıhha School Directorate, Başkent University National Disease Burden and Cost Efficiency Project 2004. Available from: http://www.toraks.org.tr. [Last accessed on 2017 Dec 16].
14. Marras TK, Chan CK. Use of guidelines in treating community‑acquired pneumonia. Chest 1998;113:1689‑94.
15. Capelastegui A, España PP, Quintana JM, Gorordo I, Ortega M, Idoiaga I, et al. Improvement of process‑of‑care and outcomes after implementing a guideline for the management of community‑acquired pneumonia: A controlled before‑and‑after design study. Clin Infect Dis 2004;39:955‑63.
16. Dean NC, Silver MP, Bateman KA, James B, Hadlock CJ, Hale D, et al. Decreased mortality after implementation of a treatment guideline for community‑acquired pneumonia. Am J Med 2001;110:451‑7.
17. Nathwani D, Rubinstein E, Barlow G, Davey P. Do guidelines for community‑acquired pneumonia improve the cost‑effectiveness of hospital care? Clin Infect Dis 2001;32:728‑41.
18. Gökırmak M, Hasanoğlu HC, Yıldırım Z, Köksal N, Orhan Z, Evliyagil SS. The Success Rates in Community-Acquired Pneumonia Treated Consistently or Inconsistently with the Turkish Thoracic Society Pneumonia Guidelines. Tüberk Toraks 2001;49:297-311.
19. Dambrava PG, Torres A, Vallès X, Mensa J, Marcos MA, Peñarroja G, et al. Adherence to guidelines’ empirical antibiotic recommendations and community‑acquired pneumonia outcome. Eur Respir J 2008;32:892‑901.
20. Mortensen EM, Restrepo MI, Anzueto A, Pugh JA. Antibiotic therapy and 48‑hour mortality for patients with pneumonia. Am J Med 2006;119:859‑64.
21. Frei CR, Restrepo MI, Mortensen EM, Burgess DS. Impact of guideline‑concordant empiric antibiotic therapy in community‑acquired pneumonia. Am J Med 2006;119:865‑71.
22. Özlü T, Bülbül Y, Alataş F, Arseven O, Coşkun AŞ, Çilli A, et al. Turkish Thoracic Society Consensus Report on Diagnosis and treatment of Community Acquired Pneumonia. Turk Toraks Dergisi 2009;10 (Suppl 9):1-16.
23. Cömert S, Doğan C, Fidan A. The Correlation of Different Pneumonia Severity Classifications with Each Other According to the Indications for Hospitalization. Türk Toraks Derg 2012;13:158-62.
24. Póvoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, et al. C‑reactive protein as a marker of ventilator‑associated pneumonia resolution: A pilot study. Eur Respir J 2005;25:804‑12.
25. Seligman R, Meisner M, Lisboa TC, Hertz FT, Filippin TB, Fachel JM, et al. Decreases in procalcitonin and C‑reactive protein are strong predictors of survival in ventilator‑associated pneumonia. Crit Care 2006;10:R125.
26. Christ‑Crain M, Jaccard‑Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al. Effect of procalcitonin‑guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster‑randomised, single‑blinded intervention trial. Lancet 2004;363:600‑7.

APA	AKINCI ÖZYÜREK B, Ertürk A, AYDEMİR Y, Sen N, ALİZOROĞLU D, ÖZHAN M (2018). The approach to community-acquired pneumonia: A survey study. , 93 - 98. 10.4103/ejop.ejop_37_18
Chicago	AKINCI ÖZYÜREK Berna,Ertürk Arzu,AYDEMİR Yusuf,Sen Nazan,ALİZOROĞLU Dursun,ÖZHAN Mustafa Hikmet The approach to community-acquired pneumonia: A survey study. (2018): 93 - 98. 10.4103/ejop.ejop_37_18
MLA	AKINCI ÖZYÜREK Berna,Ertürk Arzu,AYDEMİR Yusuf,Sen Nazan,ALİZOROĞLU Dursun,ÖZHAN Mustafa Hikmet The approach to community-acquired pneumonia: A survey study. , 2018, ss.93 - 98. 10.4103/ejop.ejop_37_18
AMA	AKINCI ÖZYÜREK B,Ertürk A,AYDEMİR Y,Sen N,ALİZOROĞLU D,ÖZHAN M The approach to community-acquired pneumonia: A survey study. . 2018; 93 - 98. 10.4103/ejop.ejop_37_18
Vancouver	AKINCI ÖZYÜREK B,Ertürk A,AYDEMİR Y,Sen N,ALİZOROĞLU D,ÖZHAN M The approach to community-acquired pneumonia: A survey study. . 2018; 93 - 98. 10.4103/ejop.ejop_37_18
IEEE	AKINCI ÖZYÜREK B,Ertürk A,AYDEMİR Y,Sen N,ALİZOROĞLU D,ÖZHAN M "The approach to community-acquired pneumonia: A survey study." , ss.93 - 98, 2018. 10.4103/ejop.ejop_37_18
ISNAD	AKINCI ÖZYÜREK, Berna vd. "The approach to community-acquired pneumonia: A survey study". (2018), 93-98. https://doi.org/10.4103/ejop.ejop_37_18

APA	AKINCI ÖZYÜREK B, Ertürk A, AYDEMİR Y, Sen N, ALİZOROĞLU D, ÖZHAN M (2018). The approach to community-acquired pneumonia: A survey study. Eurasian Journal of Pulmonology, 20(2), 93 - 98. 10.4103/ejop.ejop_37_18
Chicago	AKINCI ÖZYÜREK Berna,Ertürk Arzu,AYDEMİR Yusuf,Sen Nazan,ALİZOROĞLU Dursun,ÖZHAN Mustafa Hikmet The approach to community-acquired pneumonia: A survey study. Eurasian Journal of Pulmonology 20, no.2 (2018): 93 - 98. 10.4103/ejop.ejop_37_18
MLA	AKINCI ÖZYÜREK Berna,Ertürk Arzu,AYDEMİR Yusuf,Sen Nazan,ALİZOROĞLU Dursun,ÖZHAN Mustafa Hikmet The approach to community-acquired pneumonia: A survey study. Eurasian Journal of Pulmonology, vol.20, no.2, 2018, ss.93 - 98. 10.4103/ejop.ejop_37_18
AMA	AKINCI ÖZYÜREK B,Ertürk A,AYDEMİR Y,Sen N,ALİZOROĞLU D,ÖZHAN M The approach to community-acquired pneumonia: A survey study. Eurasian Journal of Pulmonology. 2018; 20(2): 93 - 98. 10.4103/ejop.ejop_37_18
Vancouver	AKINCI ÖZYÜREK B,Ertürk A,AYDEMİR Y,Sen N,ALİZOROĞLU D,ÖZHAN M The approach to community-acquired pneumonia: A survey study. Eurasian Journal of Pulmonology. 2018; 20(2): 93 - 98. 10.4103/ejop.ejop_37_18
IEEE	AKINCI ÖZYÜREK B,Ertürk A,AYDEMİR Y,Sen N,ALİZOROĞLU D,ÖZHAN M "The approach to community-acquired pneumonia: A survey study." Eurasian Journal of Pulmonology, 20, ss.93 - 98, 2018. 10.4103/ejop.ejop_37_18
ISNAD	AKINCI ÖZYÜREK, Berna vd. "The approach to community-acquired pneumonia: A survey study". Eurasian Journal of Pulmonology 20/2 (2018), 93-98. https://doi.org/10.4103/ejop.ejop_37_18